The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective.
Official Title: A Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial Evaluating DCVax(tm)-Prostate, Autologous Dendritic Cells Loaded With Recombinant PSMA for the Treatment of Metastatic Hormone Refractory Prostate Cancer
Study ID: NCT00043212
Brief Summary: The purpose of this clinical research study is to assess the safety and efficacy of an investigational therapy called DCVax(TM)-Prostate.
Detailed Description: Patients with hormone refractory prostate cancer are eligible if they have a rising PSA or three or fewer metastatic lesions. The experimental therapy uses a patient's own white blood cells and "teaches" the cells to recognize a "flag" on prostate cancer cells. This may help the immune system destroy prostate cancer cells. Side effects reported from the Phase I/II trial include skin reactions of redness, pain \& swelling at the injection site, and short-lived headache, fever \& fatigue. Full details are available in the informed consent.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Highlands Oncology Group, Springdale, Arkansas, United States
University of California, Los Angeles, Los Angeles, California, United States
University of California, San Diego Medical Center, San Diego, California, United States
Walter Reed Army Medical Center, Washington, District of Columbia, United States
Cancer Centers of Florida, P.A., Orlando, Florida, United States
St. Francis Medical Center, Peoria, Illinois, United States
Louisiana State University, New Orleans, Louisiana, United States
Clinical Research Solutions, Las Vegas, Nevada, United States
Albany Regional Cancer Center, Albany, New York, United States
Carolinas HealthCare System, Charlotte, North Carolina, United States
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Mary Crowley Medical Research Center, Dallas, Texas, United States
Tyler Cancer Center, Tyler, Texas, United States
University of Utah, Salt Lake City, Utah, United States
Cancer Care Northwest, Spokane, Washington, United States
St. Luke's Medical Center, Milwaukee, Wisconsin, United States